Yes, good point. In fact the idea hasn’t caught on here yet . . . too early again, but better than too late I suppose. B22.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025